These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 31395294)

  • 1. Axillary-bifemoral and axillary-unifemoral artery grafts have similar perioperative outcomes and patency.
    Hardouin S; Cheng TW; Farber A; Kalish JA; Jones DW; Malas MB; Rybin D; Oriel BS; Plauche LM; Siracuse JJ
    J Vasc Surg; 2020 Mar; 71(3):862-868. PubMed ID: 31395294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative evaluation of externally supported polytetrafluoroethylene axillobifemoral and axillounifemoral bypass grafts.
    Mohan CR; Sharp WJ; Hoballah JJ; Kresowik TF; Schueppert MT; Corson JD
    J Vasc Surg; 1995 May; 21(5):801-8; discussion 808-9. PubMed ID: 7769738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved patency after axillofemoral bypass for aortoiliac occlusive disease.
    Samson RH; Showalter DP; Lepore MR; Nair DG; Dorsay DA; Morales RE
    J Vasc Surg; 2018 Nov; 68(5):1430-1437. PubMed ID: 29691098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of axillofemoral bypass for intermittent claudication.
    Levin SR; Farber A; King EG; Beck AW; Osborne NH; DeMartino RR; Cheng TW; Rybin D; Siracuse JJ
    J Vasc Surg; 2022 May; 75(5):1687-1694.e4. PubMed ID: 34954271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid surgery for bilateral lower extremity inflow revascularization.
    Jorshery SD; Luo J; Zhang Y; Sarac T; Ochoa Chaar CI
    J Vasc Surg; 2019 Sep; 70(3):768-775.e2. PubMed ID: 30837177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
    Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
    J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
    Rychlik IJ; Davey P; Murphy J; O'Donnell ME
    J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and outcome of chronic atherosclerotic infrarenal aortic occlusion.
    Ligush J; Criado E; Burnham SJ; Johnson G; Keagy BA
    J Vasc Surg; 1996 Sep; 24(3):394-404; discussion 404-5. PubMed ID: 8808961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of adjunct femoral endarterectomy in lower extremity bypass on perioperative and 1-year outcomes.
    Soden PA; Zettervall SL; Shean KE; Deery SE; Kalish JA; Healey CT; Kansal N; Schermerhorn ML;
    J Vasc Surg; 2017 Mar; 65(3):711-719.e1. PubMed ID: 27633166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillofemoral bypass for aortoiliac occlusive disease.
    Martin D; Katz SG
    Am J Surg; 2000 Aug; 180(2):100-3. PubMed ID: 11044521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of PTFE trilaminate graft versus venous graft and composite graft for below-the-knee revascularization.
    Mazzaccaro D; De Febis E; Settembrini AM; Tassinari L; Carmo M; Settembrini PG
    J Cardiovasc Surg (Torino); 2014 Oct; 55(5):685-91. PubMed ID: 25008059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative conduit for infrageniculate bypass in patients with critical limb ischemia.
    Moreira CC; Leung AD; Farber A; Rybin D; Doros G; Siracuse JJ; Kalish J; Eslami MH
    J Vasc Surg; 2016 Jul; 64(1):131-139.e1. PubMed ID: 27345506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison.
    Samson RH; Morales R; Showalter DP; Lepore MR; Nair DG
    J Vasc Surg; 2016 Sep; 64(3):638-47. PubMed ID: 27139782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thirty-year trends in aortofemoral bypass for aortoiliac occlusive disease.
    Sharma G; Scully RE; Shah SK; Madenci AL; Arnaoutakis DJ; Menard MT; Ozaki CK; Belkin M
    J Vasc Surg; 2018 Dec; 68(6):1796-1804.e2. PubMed ID: 30001912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary comparison of aortofemoral bypass to alternative inflow procedures in the Veteran population.
    McPhee JT; Madenci A; Raffetto J; Martin M; Gupta N
    J Vasc Surg; 2016 Dec; 64(6):1660-1666. PubMed ID: 27462000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Use of Anticoagulation or Dual Antiplatelet Therapy for Patients with Extra-anatomic Bypasses.
    Teveris V; Columbo J; Bartline P; Goodney P; Stone D; Suckow B
    Ann Vasc Surg; 2020 Jul; 66():272-281.e1. PubMed ID: 31931126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of failed and infected axillofemoral grafts.
    Marston WA; Risley GL; Criado E; Burnham SJ; Keagy BA
    J Vasc Surg; 1994 Sep; 20(3):357-65; discussion 365-6. PubMed ID: 8084027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillofemoral bypass: compromised bypass for compromised patients.
    Harrington ME; Harrington EB; Haimov M; Schanzer H; Jacobson JH
    J Vasc Surg; 1994 Aug; 20(2):195-201. PubMed ID: 8040942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of the FUSION vascular graft for above-knee femoropopliteal bypass.
    Assadian A; Eckstein HH;
    J Vasc Surg; 2015 Mar; 61(3):713-9.e1. PubMed ID: 25498193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.